Strong inhibitory effect of medroxyprogesterone acetate (MPA) on UDP-glucuronosyltransferase (UGT) 2B7 might induce drug-drug interactions

被引:25
作者
Huang, T. [2 ]
Fang, Z. Z. [3 ]
Yang, L. [1 ]
机构
[1] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian 116023, Peoples R China
[2] Shanghai Inst Planned Parenthood Res, Natl Populat & Family Planning Key Lab Contracept, Shanghai, Peoples R China
[3] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China
来源
PHARMAZIE | 2010年 / 65卷 / 12期
关键词
GLUCURONIDATION;
D O I
10.1691/ph.2010.0671
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
The aim of the present study was to investigate the inhibitory effects of medroxyprogesterone acetate (MPA) on four important UGT isoforms (UGT1A1, 1A6, 1A9 and 2B7). 4-methylumbelliferone (4-MU) was used as a nonselective substrate, and recombinant UGT isoforms were utilized as an enzyme source. The results showed that MPA exhibited inhibitory effects on UGT2B7 (IC50 = 29.3 +/- 1.5 mu M), with a negligible influence on other UGT isoforms. The results obtained from Lineweaver-Burk and Dixon plots showed that MPA competitively inhibited UGT2B7. The K-i value was calculated to be 7.2 mu M. Based on the concentration of MPA in human liver, the magnitude of in vivo drug-drug interaction (DDI) was predicted. The [1]/K-i value was calculated to be 0.31, which suggested that DDIs might occur when MPA was co-administered with drugs which mainly undergo UGT2B7-mediated metabolism.
引用
收藏
页码:919 / 921
页数:3
相关论文
共 11 条
[1]
Glucuronidation of the Antiretroviral Drug Efavirenz by UGT2B7 and an in Vitro Investigation of Drug-Drug Interaction with Zidovudine [J].
Belanger, Anne-Sophie ;
Caron, Patrick ;
Harvey, Mario ;
Zimmerman, Peter A. ;
Mehlotra, Rajeev K. ;
Guillemette, Chantal .
DRUG METABOLISM AND DISPOSITION, 2009, 37 (09) :1793-1796
[2]
PHARMACOKINETICS AND PHARMACODYNAMICS OF MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER PATIENTS [J].
ETIENNE, MC ;
MILANO, G ;
FRENAY, M ;
RENEE, N ;
FRANCOIS, E ;
THYSS, A ;
SCHNEIDER, M ;
NAMER, M .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (07) :1176-1182
[3]
FALKSON CI, 1992, ONCOLOGY, V49, P418
[4]
Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction [J].
Fang, Zhong-Ze ;
Zhang, Yan-Yan ;
Ge, Guang-Bo ;
Huo, Hong ;
Liang, Si-Cheng ;
Yang, Ling .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (02) :193-199
[5]
UDP-glucuronosyltransferases and clinical drug-drug interactions [J].
Kiang, TKL ;
Ensom, MHH ;
Chang, TKH .
PHARMACOLOGY & THERAPEUTICS, 2005, 106 (01) :97-132
[6]
The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential [J].
Miners, John O. ;
Mackenzie, Peter I. ;
Knights, Kathleen M. .
DRUG METABOLISM REVIEWS, 2010, 42 (01) :196-208
[7]
Memory functioning at menopause: Impact of age in ovariectomized women [J].
Nappi, RE ;
Sinforiani, E ;
Mauri, M ;
Bono, G ;
Polatti, F ;
Nappi, G .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1999, 47 (01) :29-36
[8]
Depot medroxyprogesterone acetate and basal serum prolactin levels in lactating women [J].
Ratchanon, S ;
Taneepanichskul, S .
OBSTETRICS AND GYNECOLOGY, 2000, 96 (06) :926-928
[9]
RAUTIO A, 1985, RES COMMUN CHEM PATH, V47, P305
[10]
Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid [J].
Uchaipichat, V ;
Mackenzie, PI ;
Guo, XH ;
Gardner-Stephen, D ;
Galetin, A ;
Houston, JB ;
Miners, JO .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (04) :413-423